当前位置：
X-MOL 学术
›
J. Antibiot.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Paenialvin A-D, four peptide antibiotics produced by Paenibacillus alvei DSM 29.
The Journal of Antibiotics ( IF 2.1 ) Pub Date : 2018-Sep-01 , DOI: 10.1038/s41429-017-0001-3 Jia Meng , Zheng Zhong , Pei-Yuan Qian
The Journal of Antibiotics ( IF 2.1 ) Pub Date : 2018-Sep-01 , DOI: 10.1038/s41429-017-0001-3 Jia Meng , Zheng Zhong , Pei-Yuan Qian
Four peptide antibiotics, named paenialvin A-D, were isolated from Paenibacillus alvei DSM 29. Mass spectrum analysis determined the molecular masses of paenialvin A-D to be 1891, 1875, 1877, and 1923 Da, respectively. Tandem mass spectra and nuclear magnetic resonance (NMR) were used to elucidate their chemical structures. Paenialvin A-D showed antimicrobial activity against most strains that were tested, including methicillin-resistant Staphalococcus aureus, Staphylococcus aureus, Bacillus subtilis, Loktanella hongkongensis, Escherichia coli, and Pseudomonas aeruginosa. In particular, the minimum inhibitory concentration of paenialvins against Staphalococcus aureus reached 0.8-3.2 μg/mL. Although they were cytotoxic against HeLa cells at a concentration of 50 μg/mL, the lack of hemolysis by paenialvins confirmed that they are potential candidates for anti-tumor drugs.
更新日期：2018-05-14
京公网安备 11010802027423号